Active Pharmaceutical Ingredients
Hydrochlorothiazide DC Granules are a pharmaceutical formulation containing hydrochlorothiazide, a diuretic, processed into direct compression (DC) granules for easier tablet manufacturing. The granules are used to treat high blood pressure (hypertension) and fluid retention (edema) by helping the kidneys remove extra water and salt from the body, thereby relaxing blood vessels.
| Component | Function |
|---|---|
| Hydrochlorothiazide (API) | Active ingredient – diuretic/hypertension agent |
| Microcrystalline Cellulose / Lactose | Diluent / Filler – provides bulk and compressibility |
| Povidone / HPMC / Pregelatinized Starch | Binder – ensures granule cohesion |
| Crospovidone / Croscarmellose Sodium | Disintegrant – ensures rapid tablet breakdown |
| Colloidal Silicon Dioxide / Talc | Glidant – improves flow and handling |
| Magnesium Stearate / Stearic Acid | Lubricant – reduces friction during compression |
Outsourcing DC Granules through a trusted partner like Salius Pharma can be a strategic decision to save both time and resources, without compromising on quality or compliance. Instead, partnering with Salius Pharma—a leading developer aligned with USFDA-approved and WHO-GMP-certified manufacturers in India—allows you to leverage high-quality products, seamless logistics, and professional support under one roof.
We ensure prompt and reliable shipping worldwide. Delivery times may vary depending on destination, order volume, and regulatory requirements.
Looking to source Hydrochlorothiazide DC Granules or other high-quality pharmaceutical pellet formulations?
Whether you need Active Pharmaceutical Ingredients (APIs), excipients, or regulatory support, our team is ready to provide reliable, compliant, and cost-effective solutions tailored to your market needs.
The contents of this page and any attachments are intended solely for the designated recipient(s) and may contain confidential and/or privileged information protected by law.
Any patented products are excluded from our offerings in regions where such patents are currently in force.
They are specially designed for direct compression, ensuring consistent content uniformity, smooth flow, and reproducible tablet quality.
They provide Immediate Release (IR), enabling fast dissolution and prompt therapeutic action.
The granules are stable when stored in tightly sealed containers, protected from heat, moisture, and light, maintaining quality over time.